News & Updates
Filter by Specialty:
Solriamfetol reduces sleepiness in patients with OSA, narcolepsy
24 Jan 2023
A recent study has shown the efficacy of solriamfetol as an alternative treatment for managing excessive daytime sleepiness (EDS) in patients with narcolepsy and obstructive sleep apnoea (OSA).
Solriamfetol reduces sleepiness in patients with OSA, narcolepsy
24 Jan 2023Some antihypertensive medications may lower dementia risk
24 Jan 2023
byStephen Padilla
Use of angiotensin II (ATII)-stimulating antihypertensive medication (AHM), angiotensin receptor blockers (ARBs), and dihydropyridine calcium channel blockers (CCBs) helps reduce the risk of dementia over a decade, but this beneficial effect decreases over time, according to a study.
Some antihypertensive medications may lower dementia risk
24 Jan 2023Objective response to systemic therapy linked to overall survival in unresectable HCC
23 Jan 2023
byStephen Padilla
Objective response to first-line systemic therapy with lenvatinib or sorafenib independently predicts overall survival (OS) in individuals with unresectable hepatocellular carcinoma (HCC), as shown by the subanalysis of the REFLECT study.